WHave you ever heard of GHRH? It stands for growth hormone releasing hormone. Sermorelin is a peptide analog for GHRH. Peptide analogs are typically synthetic short chains of amino acids that mimic or replace naturally occurring substances in the human body. These peptide analogs can be used as supplements for individuals who struggle to produce adequate levels of chemicals naturally. Conversely, different peptide analogs can be used to leverage, dictate, redirect, or change naturally occurring chemicals to satisfy other desired results.
Note: Sermorelin is offered by gurupeptides.com for research laboratory use only and is no way intended for self-supplementation.
Breakthroughs and Research Success
The medical community has been aware of Sermorelin’s existence for just over thirty years. Not until the mid 1990’s did technology progress to a point where higher education institutions, universities, and pharmaceutical companies could adequately experiment with Sermorelin. These different entities have formulated interesting opinions, hypotheses, and research projects relating to the potential benefits of Sermorelin use in humans…
In the late 1980’s, research groups were just starting to understand what Sermorelin was. In 1987, an elaborate laboratory project observing the effects that Sermorelin had on individuals struggling with human growth hormone deficiency. The results of the study, though not entirely conclusive, led to a boom in research around the world. Children suffering from deficiencies much like HGH were a soft spot of medical research at the time. The study concluded that though dosing seemed to be effective in 14 of the 18 patients, ideal dose regimens still needed to be established.
By the time the millennium ended, Sermorelin was widely considered to be one of the more effective and promising treatment methods for individuals suffering from human growth hormone deficiency. Adis International Limited, a leading international publisher of drug-focused content and solutions from Auckland, New Zealand, completed an impressive report on the observed efficacy of Sermorelin over the course of a 12 month treatment regimen. In the publication, Adis states that not only does Sermorelin seem to be a stable solution as an HGH deficiency remedy, but it also lacks any real adverse side effects to speak of. Although the conclusion of the publication described Sermorelin as a “well tolerated” solution, it goes on to admit the end data is still limited, no matter how promising it was.
Fast forwarding several years, Richard F. Walker of the International Society for Applied Research in Aging, published that Sermorelin was undeniably effective when used in human growth hormone regulation and treatment programs. Though the solution is entirely safe for human supplementation, he goes on to admit there may be a single negative trait to its utilization: morals and ethics. Walker states, “there is the question of lawful practice” and that the legality of using something to alter natural genetic state could be called into question.
1 Ross, R J, et al. “Treatment of Growth-Hormone Deficiency with Growth-Hormone-Releasing Hormone.” Current Neurology and Neuroscience Reports., U.S. National Library of Medicine, 3 Jan. 1987, www.ncbi.nlm.nih.gov/pubmed/2879138.
2 Prakash, A, and K L Goa. “Sermorelin: a Review of Its Use in the Diagnosis and Treatment of Children with Idiopathic Growth Hormone Deficiency.” Current Neurology and Neuroscience Reports., U.S. National Library of Medicine, Aug. 1999, www.ncbi.nlm.nih.gov/pubmed/18031173.
3 Walker, Richard. “Sermorelin: A better approach to management of adult-onset growth hormone insufficiency?” Clinical Intervention of Aging., U.S. National Library of Medicine, Dec. 2006, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699646/.